Dollar-a-dose, off-patent drug being marketed in the US for $89,000 as a muscular dystrophy treatment

Deflazacort, a steroid, can be purchased online from non-US sources for $1.00, but now it’s being marketed by Illinois’s Marathon Pharmaceuticals for $89,000 as Emflaza, to treat Duchenne muscular dystrophy, which predominantly affects men in their 20s.
(more…)

Write a comment...